New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 2, 2014
10:00 EDTSBS, DLAKY, EPB, BZH, TRMB, OHI, HRL, CJES, BNPQY, VE, NGLS, MM, HOG, BMY, USBOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: BNP Paribas (BNPQY) downgraded to Neutral from Overweight at HSBC... Beazer Homes (BZH) downgraded to Neutral from Buy at Sterne Agee... Bristol-Myers (BMY) downgraded to Equal Weight from Overweight at Barclays... C&J Energy (CJES) downgraded to Equal Weight at Stephens... El Paso Pipeline (EPB) downgraded to Sell from Neutral at Goldman... Harley-Davidson (HOG) downgraded to Market Perform from Strong Buy at Raymond James... Hormel Foods (HRL) downgraded at Credit Suisse... Lufthansa (DLAKY) downgraded to Equal Weight from Overweight at Barclays... Millennial Media (MM) downgraded at Evercore... Omega Healthcare (OHI) downgraded to Neutral from Buy at Goldman... Saneamento Basico (SBS) downgraded to Sector Perform from Outperform at Scotia... Targa Resources Partners (NGLS) downgraded to Equal Weight at Barclays... Trimble (TRMB) downgraded to Neutral from Buy at Janney Capital... U.S. Bancorp (USB) downgraded at RW Baird... Veolia Environment (VE) downgraded to Equal Weight from Overweight at Morgan Stanley.
News For BNPQY;BZH;BMY;CJES;EPB;HOG;HRL;DLAKY;MM;OHI;SBS;NGLS;TRMB;USB;VE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 11, 2014
09:16 EDTCJESCitadel Advisors reports 5.1% passive stake in C&J Energy
Subscribe for More Information
December 10, 2014
14:13 EDTTRMBTrimble confirms unmanned aircraft exemption granted by FAA
Trimble announced that the Federal Aviation Administration has granted an exemption that will allow the company to conduct commercial operation of its Trimble UX5 Aerial Imaging Solution in the U.S. The Trimble UX5 is an unmanned fixed-wing aircraft targeted at the surveying, agriculture, oil & gas, mining, construction, environmental industries.
12:06 EDTHRLUSDA lowers 2014 meat production forecast
Subscribe for More Information
11:27 EDTUSBU.S. Bancorp CFO says would consider special dividend
Subscribe for More Information
10:43 EDTTRMBTrimble among those approved for drones by FAA
Subscribe for More Information
10:00 EDTUSBU.S. Bancorp long-term goals include ROE 16%-19%
Subscribe for More Information
06:08 EDTBMYBristol-Myers partners with Ono Pharma and Kyowa Hakko Kirin for oncology trial
Subscribe for More Information
December 9, 2014
16:35 EDTBMYBristol-Myers raises dividend to 37c per share from 36c per share
Subscribe for More Information
14:42 EDTUSBFed sees setting capital surcharge up to 4.5% for big U.S. banks, Bloomberg says
Bloomberg cites surcharge estimates in Federal Reserve staff memo. Publicly traded companies in the space include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
08:25 EDTBMYBristol-Myers data positive, says BMO Capital
Subscribe for More Information
December 8, 2014
13:32 EDTBMYPfizer, Bristol-Myers announce results of human study on Eliquis
Bristol-Myers Squibb Company (BMY) and Pfizer (PFE) announced results of the first human study evaluating the reversal of the anticoagulant effect of Eliquis by 4-factor prothrombin complex concentrates in healthy subjects. The study results demonstrated that both PCCs, Sanquin’s Cofact and CSL Behring’s Beriplex P/N reversed the steady-state pharmacodynamic effects of Eliquis in several coagulation assessments, including endogenous thrombin potential. The full data will be presented today during the Antithrombotic Therapy: Anticoagulant Therapy session at the 56th annual meeting of the American Society of Hematology in San Francisco, CA. The study was an open label, randomized, placebo-controlled, three-period crossover study in 15 healthy, adult subjects. Within each period, subjects received Eliquis 10 mg twice daily. On day four, three hours after Eliquis administration, subjects received a 30-minute infusion of 4-factor PCCs, either 50 IU/kg Cofact or Beriplex P/N, or an equivalent volume of saline solution. The effect of Cofact and Beriplex P/N on the pharmacodynamics of Eliquis was based upon changes in endogenous thrombin potential, a measure of thrombin-mediated coagulation. Treatment periods were separated by an 11-day washout, after which the alternate treatment was administered. In this study, no serious adverse events, bleeding-related events or signs of thrombosis were reported with Eliquis administration with or without PCC treatment. Overall, these data demonstrate that Cofact and Beriplex P/N reversed the steady-state pharmacodynamic effects of Eliquis as measured by ETP and support further evaluation of PCCs in the management of patients treated with Eliquis who require reversal of its anticoagulant effect.
10:00 EDTUSBOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTOHI, DLAKYOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Antero Resources (AR) upgraded to Buy from Neutral at Citigroup... Apache (APA) upgraded to Buy from Neutral at Citigroup... Applied Materials (AMAT) upgraded to Buy from Hold at Deutsche Bank... Arch Capital (ACGL) upgraded to Outperform from Market Perform at BMO Capital... CU Bancorp (CUNB) upgraded to Buy from Hold at Sandler O'Neill... Calpine (CPN) upgraded to Outperform from Neutral at Macquarie... Commerzbank (CRZBY) upgraded to Market Perform from Underperform at Keefe Bruyette... EastGroup Properties (EGP) upgraded to Neutral from Underperform at Credit Suisse... Enbridge Energy Management (EEQ) upgraded to Equal Weight at Morgan Stanley... Enbridge Energy (EEP) upgraded to Equal Weight from Underweight at Morgan Stanley... GasLog (GLOG) upgraded to Buy from Hold at Stifel... Hoegh LNG (HMLP) upgraded to Buy from Neutral at UBS... Illinois Tool Works (ITW) upgraded to Buy from Accumulate at Global Hunter... LaSalle Hotel (LHO) upgraded at Morgan Stanley... Lufthansa (DLAKY) upgraded to Buy from Neutral at Nomura... NASDAQ (NDAQ) upgraded to Outperform from Market Perform at Keefe Bruyette... Newfield Exploration (NFX) upgraded to Buy from Neutral at Citigroup... Omega Healthcare (OHI) upgraded to Buy from Hold at Jefferies... Orange SA (ORAN) upgraded to Conviction Buy from Neutral at Goldman... SM Energy (SM) upgraded to Outperform from Market Perform at BMO Capital... Southwest (LUV) upgraded at Goldman... TSMC (TSM) upgraded to Buy from Neutral at BofA/Merrill... United Technologies (UTX) upgraded at Bernstein... eBay (EBAY) upgraded to Buy from Hold at Stifel.
06:35 EDTUSBValue of Wall Street's M&A bankers has risen, NY Times says
The value of Wall Street's bankers who advise large companies seems to be increasing, while traders are becoming less valuable, according to The New York Times. Bankers who work on M&A deals are expecting their bonuses to increase, while traders anticipate that their compensation will drop, the newspaper added. Furthermore, banks seem to be going the extra mile to hire top notch bankers, the newspaper stated. Publicly traded large banks include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
05:59 EDTUSBU.S. Bancorp downgraded to Underperform from Market Perform at Keefe Bruyette
Subscribe for More Information
05:56 EDTOHIOmega Healthcare upgraded to Buy from Hold at Jefferies
Subscribe for More Information
05:53 EDTBMYStocks with implied volatility movement; BSX BMY
Subscribe for More Information
05:33 EDTDLAKYLufthansa upgraded to Buy from Neutral at Nomura
December 7, 2014
14:10 EDTBMYAmerican Society of Hematology to hold a meeting
Subscribe for More Information
13:06 EDTBMYBMY announces positive results in Phase 1b trial evaluating Opdivo
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use